The global infection prevention market showcases promising future trends, with the latest forecast estimating a strong growth trajectory. The sector, valued at US$ 40.8 billion in 2023, is predicted to grow at a Compound Annual Growth Rate (CAGR) of 4% over the next ten years, reaching approximately US$ 60.6 billion by 2033. This dynamic growth trend is a testament to the increasing demand for innovative solutions and cutting-edge technologies in the infection prevention sphere.
Fueling this expansion are factors such as increased awareness about healthcare-associated infections, the urgent requirement for rigorous infection control regimens and a proactive approach to global health and safety. The COVID-19 pandemic catalyzed a significant growth curve in the sales of infection prevention kits, epitomizing the importance of social distancing and hygiene maintenance across all sectors, not limited to healthcare.
Numerous governmental initiatives emphasizing cleanliness have provided an additional thrust to the market, leading to a heightened consumer awareness about the importance of hygiene. According to the World Health Organization (WHO), the rising incidence of strokes and pulmonary diseases anticipated to massively impact the market. The pressing need for ensuring hygiene in hospital operations, particularly among patients admitted due to these health concerns, is expected to substantially boost adoption rates of infection prevention products within the forecast period.
However, the market faces challenges in supply chain disruptions and unstable prices for raw materials. FMI analysts, considering these variables, infer that the growth of this market will be propelled by factors including increased surgical procedures, growing governmental initiatives, escalating hygiene awareness, among others, during the forecast period. The infection prevention market landscape is largely distinguished by key players focusing on mergers, acquisitions, and strategic partnerships. Strong investments are also being made in the technological enhancements of healthcare sector, fostering better product quality and fostering market growth.
The infection prevention market segmentation by product type, end user and region offers a comprehensive breakdown, revealing key insights for strategic planning. On one hand, key players such as Sterigenics, a subsidiary of Sotera Health, announced an increased electron beam sterilization capacity in May 2022, supporting healthcare industry needs. On the other hand, the infection prevention market’s potential growth signifies an exciting opportunity for professionals in the field. Continued market expansion, technological advancements, strategic collaborations, and increasing consumer awareness all contribute to the strengthening position of the infection prevention market.